Hope for seizure control blooms from unexpected source

May 23, 2014 by Paul Mayne, University of Western Ontario

Aided by former graduate student Nadeem Ashraf, and a Himalayan flower, Robarts Research Institute scientist Michael Poulter may be getting to the root of a solution to epileptic seizures.

Ashraf, a Pakistan native, didn't actually bring the flower itself to Poulter in May 2011, but rather a pure synthesized molecule, identical to the one in the plant's root, which had been studied for almost a decade by scientists at the International Center for Chemical and Biological Sciences at the University of Karachi.

"He showed me that he had this and told me there has already been a publication on its activity. So, I looked at it and saw it seemed to do something," Poulter said. "According to this report, it looks to work. But how it works, we didn't know. So, I said, 'Let's let see how it works.'"

And they did just that. What they discovered shocked even a veteran researcher like Poulter.

"When I could identify what it did, and didn't do," he continued, "what it does makes sense – it suppresses seizures. It was really quite remarkable."

Regular brain rhythms are high frequency and low amplitude. In those with epilepsy, however, the brain synchronizes its activities to the point where brainwaves become high amplitude and low frequency.

"So, you go from fast and small to large and slow, and that is an abnormal brain rhythm, which precipitates and inappropriate behavior or seizure," Poulter said. "The trick in the treatment of epilepsy is to prevent those high-amplitude, hyper-synchronized activities."

All epilepsy medications – with between 15 and 20 currently on the market – aim to do the same thing, and 70 per cent do the job. But there are side effects such as memory loss, rashes and auto-immune reactions.

Drawn from the lavender-coloured delphinium denudatum flower, the root extract molecule blocks the activity of an ion channel, called the sodium channel, responsible for the excitation of nerve cells.

"When a sodium channel activates, it activates the neuron. When you have excess activation, you can try to dampen down that activity a little bit, but not completely, or you would die," Poulter said. "You're trying to dampen down the activity that is inappropriately high due to epilepsy.

"That's what we know (the root) does and that makes sense. What we don't know is why this particular drug prevents the progression of the seizures in the animal model. There are other drugs out there that will block sodium channels, but do not stop the progression of the seizures. We still don't understand that."

While excited around the early findings, Poulter remains cautious.

"Everybody knows it is still a very, very high-risk proposition," he said. "The reason is, in normal progression of a drug to the clinics, you have to show it first works acceptably in animal models, and that costs loads of cash."

In the next phase, which Poulter referred to as "the valley of death," the molecule is sent to a company that does long-term toxicity tests, which usually makes or breaks a drug's success.

"At the end of all that, you slowly open up the report because you just spent close to a million dollars, and if it passes, then you're ready to put it into people. If not, and you have money left, you go back to the start and reformulate the chemistry," Poulter said, noting he is still a couple of years away from that point.

Poulter has obtained funding from the Ontario Brain Institute, and other private-sector investors, to begin a pharmaceutical company to commercially develop this promising drug when, and if, it gains approval.

Poulter said some of the greatest finds in medicine come from the last place you would think. For example, Amazon jungle locals hunt with poison blow darts with an active ingredient called tubocurarine, an alkaloid found in the bard of a South American vine. That same ingredient has been used as a muscle relaxant during surgery to prevent unwanted movement of the patient.

"There is precedent for natural products having real effects that become mainstay and are in use," Poulter said. "No doubt, there are molecules out there. People spend their careers going through the jungles looking for things that work, called ethnopharamacology."

But while undiscovered remedies remain, Poulter cautions their efficacy is anecdotal until put through the paces.

"Nobody in the Amazon jungle sets up a double-blind, cross-over trial of the local fauna to see whether or not it cures spider bites," he said. "These things kind of, by happenstance, fall into our laps, and basically, that's what happened here."

Explore further: Can epileptic seizures be prevented or predicted?

Related Stories

Can epileptic seizures be prevented or predicted?

March 31, 2014
A biomedical engineering professor at the Institute of Biomaterials & Biomedical Engineering (IBBME) and the Edward S. Rogers Sr. Department of Electrical & Computer Engineering (ECE), Bardakjian works with a team of neurological ...

Important breakthrough in identifying effect of epilepsy treatment

October 31, 2013
50 years after valproate was first discovered, research published today in the journal Neurobiology of Disease, reports how the drug works to block seizure progression.

US doctors call for more study of pot for seizures (Update)

March 3, 2014
A medical group of epilepsy experts on Monday called on the U.S. government to reconsider classifying marijuana as a dangerous drug so its impact on seizures can be studied.

Recommended for you

Cognitive training helps regain a younger-working brain

January 23, 2018
Relentless cognitive decline as we age is worrisome, and it is widely thought to be an unavoidable negative aspect of normal aging. Researchers at the Center for BrainHealth at The University of Texas at Dallas, however, ...

Lifting the veil on 'valence,' brain study reveals roots of desire, dislike

January 23, 2018
The amygdala is a tiny hub of emotions where in 2016 a team led by MIT neuroscientist Kay Tye found specific populations of neurons that assign good or bad feelings, or "valence," to experience. Learning to associate pleasure ...

Your brain responses to music reveal if you're a musician or not

January 23, 2018
How your brain responds to music listening can reveal whether you have received musical training, according to new Nordic research conducted in Finland (University of Jyväskylä and AMI Center) and Denmark (Aarhus University).

New neuron-like cells allow investigation into synthesis of vital cellular components

January 22, 2018
Neuron-like cells created from a readily available cell line have allowed researchers to investigate how the human brain makes a metabolic building block essential for the survival of all living organisms. A team led by researchers ...

Finding unravels nature of cognitive inflexibility in fragile X syndrome

January 22, 2018
Mice with the genetic defect that causes fragile X syndrome (FXS) learn and remember normally, but show an inability to learn new information that contradicts what they initially learned, shows a new study by a team of neuroscientists. ...

Epilepsy linked to brain volume and thickness differences

January 22, 2018
Epilepsy is associated with thickness and volume differences in the grey matter of several brain regions, according to new research led by UCL and the Keck School of Medicine of USC.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.